Click to Share
 

Filter News
Show All Results
News By Country
News By Tag
Oncology Remove


August 2019
FrThWeTuMoSuSa
23222120191817

Public Company News

Business Press Releases

Oncology Press Releases

+ Alert
+ Feed
Exclusive News
Topics Locations Industries Dates

By Greystone Research Associates
Big Pharma Focusing on Recent Successes while Smaller Players Bet on Novel Therapies According to Greystone Research Associates
By Biosceptre International
Biosceptre Acting Chair Sir Greg Winter wins Nobel prize, refines focus to Science Advisory Board and cedes to new Chair Andrew Walton-Green
By AUM Biosciences
National Cancer Centre singapore joins efforts with Singapore-based AUM Biosciences to develop new cancer drugs
By Biosceptre International Limited
Biosceptre has initiated its Phase I clinical trial of the peptide vaccine BIL06v, with the first patient treated at the initial trial site on 16th of August 2018.
By Forward Science
Almost a year after one of the most catastrophic disasters to hit the United States, Forward Science has partnered with local dental professionals affected by Hurricane Harvey to rebuild their practices.
By SMi
SMi Group reports: a comprehensive field overview and thought-provoking discussions at SMi's Immuno-Oncology Conference taking place on the 26 - 27 September in London.
By American Health Council
The American Health Council recently appointed Brittany Bento, PA-C to its Board of Physicians for her dedication to improving others' lives. A surgical physician assistant at Memorial Sloan Kettering Cancer Center in New Jersey, Ms.
By Bioprognos SL
It is expected that the new test will save up to 90% of unnecessary breast biopsies that are usually done to confirm malignancy in suspicious findings in diagnostic imaging procedures (such as all classified as BI-RADS 3 and BI-RADS 4).
By Forward Science
Study confirms SalivaMAX™ is clinically proven as a safe and effective method for the reduction of oral mucositis
By NMS Group S.p.A.
SARI, a Chinese market-leader biotech investment company, is pleased to announce that it has closed the previously announced agreement to acquire the 90% interests in NMS Group S.p.A., effective from today.
By Biosceptre International
The proposed Phase I clinical trial for BIL06v (anti-cancer vaccine) was granted conditional approval by the Bellberry Ethics committee on 21st February 2018.
By SciTech Development LLC
SciTech's Oncology Drug Granted Orphan Status (GROSSE PONTE FARMS, MI) February 1, 2018 - SciTech Development is pleased to announce that the U.S.
By MoBiTec GmbH
This fluorescence sensor-based Cell Stress Kit detects cellular stress and unfolded protein response and is important for researchers working in drug discovery, neurodegenerative diseases, and oncology.
12681405
By www.biosceptre.com
Biosceptre has received over £8M into its series A raise which will be used to resource the next stage of the companies' development; progression into the clinic of Biosceptre's first systemic products against novel oncology target nfP2X7.
By Market Research Hub
Global market for oncology information systems is referred to the market of the digital systems that are designed to keep a track of the prolonged treatment patterns of cancer treatment.
By European Medical Journal
Welcome to this year's issue of EMJ Oncology, which is filled with the latest developments from the world of cancer studies.
12666522
By Perago Contract Specialists, LLC
Board Certified Hematologist/Oncologists Physicians Are Needed For Locum Tenens Positions in Albuquerque, New Mexico With The Department of Veterans Affairs.
By Parascript
Parascript showcases AccuDetect CAD, for early breast cancer prevention at industry trade show in Berlin, Germany
12660468
By SMi Group
SMi Group has announced that Johnathan Zalevsky, Senior Vice President Biology & Preclinical Development, Nektar Therapeutics will be chairing day two of the 6th annual Cancer Vaccines conference, which will be taking place on September 27th &...

Page: 1 Page updated every 10 minutes


Like PRLog?
9K2K1K
Click to Share